ARTICLE SUMMARY:
Pathology is moving from a laboratory discipline of microscopic discernment to one centered around data-rich digital images and AI. In the process, it’s becoming the specialty most able to drive precision medicine into the future. Insights from digital pathology company Proscia.
“Most of your readers probably don’t think much about pathology,” says Nathan Buchbinder, co-founder and chief strategy officer of Proscia, a leading independent company in the digital pathology and AI space. “But the pathologist and pathology are quickly becoming integral to the precision medicine paradigm.” Not just as a provider of diagnoses therein, he asserts, but as “the real driver of personalized and precision medicine and informatics data-driven decision-making in the healthcare ecosystem.”
Pathology is the medical specialty devoted to diagnosing disease by examining tissues, cells, and bodily fluids. Underpinning just about all of how we understand and treat disease, it plays a key role in diagnosing cancers and tumors, blood and bone marrow disorders, inflammatory and autoimmune diseases, infectious diseases, and genetic and developmental diseases, among others.
